It is currently Mon Apr 24, 2017 4:30 am
Carl Icahn raises the stakes for Big Pharma
The financier has set a high benchmark for bidders for the biotech firm. Fortune's John Simons explains why Big Pharma is likely to pay top dollar for a very risky asset.
Total posts 237572 • Total topics 25811 • Total members 17085